Skip to main content

Table 3 Comparison of baseline observed and predicted utility scores

From: Exploring the validity of estimating EQ-5D and SF-6D utility values from the health assessment questionnaire in patients with inflammatory arthritis

  

Observed

Predicted

Difference

(Observed-Predicted)

 

n

Mean

(SD)

Mean

(SD)

R 2

Mean

(95% CI)

95% reference range

EQ-5D

      

STIVEA

224

0.47

(0.30)

0.53

(0.25)

0.35

0.06

(0.02, 0.09)

-0.44 to 0.56

BROSG

453

0.59

(0.22)

0.59

(0.19)

0.20

0.01

(-0.01, 0.03)

-0.42 to 0.44

BSRBR

795

0.40

(0.33)

0.44

(0.26)

0.35

0.04

(0.02, 0.06)

-0.49 to 0.57

SF-6D

      

STIVEA

224

0.57

(0.13)

0.67

(0.07)

0.45

0.10

(0.09, 0.11)

-0.09 to 0.29

BROSG

453

0.63

(0.13)

0.68

(0.07)

0.34

0.05

(0.04, 0.05)

-0.16 to 0.25

BSRBR

795

0.53

(0.11)

0.63

(0.07)

0.51

0.09

(0.09, 0.10)

-0.06 to 0.25

  1. Abbreviations: BROSG = British Rheumatoid Outcome Study Group, BSRBR = British Society for Rheumatology Biologics Register, EQ-5D = EuroQol-5D, SF-6D = Short Form-6D, STIVEA = Steroids In Very Early Arthritis